...
首页> 外文期刊>Journal of addictive diseases: the official journal of the ASAM, American Society of Addiction Medicine >Prevalence of ADHD symptom malingering, nonmedical use, and drug diversion among college-enrolled adults with a prescription for stimulant medications
【24h】

Prevalence of ADHD symptom malingering, nonmedical use, and drug diversion among college-enrolled adults with a prescription for stimulant medications

机译:ADHD症状发生患病率,非医学用途和高校成人中的药物转移,具有兴奋剂的处方药

获取原文
获取原文并翻译 | 示例
           

摘要

Malingering of ADHD symptoms is a potential means of nonmedical use of prescription stimulants (NMUPS). The Subtle ADHD Malingering Screener (SAMS) provides a potential avenue for identification of symptom malingering. However, no real world evidence of this scale has been published to date. The goal of this study was to examine patterns of use of stimulant prescriptions and to evaluate the ability of the SAMS to identify NMUPS. This study employed a cross-sectional observational design to administer an online, self-administered survey instrument in a convenience sample of college-enrolled young adults with a prescription for stimulant medications at a campus pharmacy. Respondents were asked about their prescription characteristics, nonmedical use and drug diversion behavior, along with ratings on the SAMS. Over 33% of respondents self-reported past-year NMUPS and 18% reported past-year drug diversion. Over 35% of respondents rated NMUPS as being slight or no risk and 55% were classified by the SAMS as likely to be malingering or exaggerating their symptoms. Individuals reporting past-year NMUPS or diversion consistently scored higher on the SAMS. The SAMS showed potential for future application in the pharmacy setting. Further research is needed to evaluate the relationship of SAMS to NMUPS or drug diversion. The results of this study also highlight several growing issues with the diagnosis and treatment of ADHD among young adults enrolled in college. Addressing perception of risk, social norms, and providing healthcare professionals with tools to prevent misdiagnosis is critical to the management of this issue.
机译:恶性ADHD症状是非医疗使用处方兴奋剂(NMUP)的潜在手段。微妙的Adhd Maleringering筛选器(Sams)提供了潜在的途径,用于识别症状恶性。但是,迄今为止没有公布这种规模的现实世界证据。本研究的目的是研究兴奋剂处方的使用模式,并评估SAM识别NMUP的能力。本研究采用了横断面观测设计,在英语注册的年轻成年人的便利样本中进行了横截面观测设计,在校园药房的兴奋剂药物处方。受访者被问及他们的处方特征,非医疗和药物转移行为以及SAM的评级。超过33%的受访者自我报告过去一年的NMUPS和18%的过去一年的药物转移。超过35%的受访者评分为少量或没有风险,55%被萨姆分类为可能发生恶意或夸大他们的症状。在SAM上报告过去一年的NMUPS或转移的个人始终如一地得分。 SAMS显示了药房环境中未来应用的潜力。需要进一步的研究来评估SAMS与NMUPS或药物转移的关系。该研究的结果还突出了患有在大学注册的年轻成年人中ADHD的诊断和治疗的几个日益增长的问题。解决风险,社会规范和提供医疗专业人员的感知,以防止误诊的工具是对本问题的管理至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号